Clinical Trial

Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29

Study acronym: ShorTrip
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of the ShorTrip trail is to evaluate the activity and the safety of total neoadjuvant strategy with FOLFOXIRI as consolidation therapy preceded by short-course radiotherapy and followed by surgery in LARC patients.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-02-14; most recent amendment 2026-07-23.
Status change: Recruiting → Active, Not Recruiting 2024-03-05
Trial Details
NCT Number NCT05253846
Lead Sponsor Gruppo Oncologico del Nord-Ovest
Conditions Locally Advanced Rectal Cancer
Enrollment 63 participants
Start Date 2022-01-25
Primary Completion 2025-01-05 (estimated)
Study Completion 2028-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-24